H syndrome: novel and recurrent mutations in SLC29A3
2010; Oxford University Press; Volume: 162; Issue: 5 Linguagem: Inglês
10.1111/j.1365-2133.2010.09653.x
ISSN1365-2133
AutoresTannu Priya, N. Philip, Vered Molho‐Pessach, Tiffany Busa, Ashwin Dalal, Abraham Zlotogorski,
Tópico(s)Ubiquitin and proteasome pathways
ResumoThe H syndrome (OMIM 612391) is a recently described autosomal recessive disorder characterized by cutaneous hyperpigmentation, hypertrichosis, hepatosplenomegaly, heart anomalies, hearing loss, hypogonadism, short stature (low height), hyperglycaemia/diabetes mellitus, hallux valgus, and fixed flexion contractures of the toe and finger joints.1, 2 Histologically, there is an inflammatory infiltrate consisting mainly of histiocytes, later replaced by fibrosis of the deep dermis and subcutis.3 In total, 31 patients have been reported in the literature with the clinical phenotype characteristic of this syndrome.1–7
Referência(s)